KR20230111814A - Method for manufacturing yogurt containing rice milk - Google Patents
Method for manufacturing yogurt containing rice milk Download PDFInfo
- Publication number
- KR20230111814A KR20230111814A KR1020220007730A KR20220007730A KR20230111814A KR 20230111814 A KR20230111814 A KR 20230111814A KR 1020220007730 A KR1020220007730 A KR 1020220007730A KR 20220007730 A KR20220007730 A KR 20220007730A KR 20230111814 A KR20230111814 A KR 20230111814A
- Authority
- KR
- South Korea
- Prior art keywords
- porridge
- tarak
- yogurt
- rice flour
- omega
- Prior art date
Links
- 235000013618 yogurt Nutrition 0.000 title claims abstract description 72
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 35
- 238000000034 method Methods 0.000 title claims description 16
- 235000020195 rice milk Nutrition 0.000 title 1
- 235000021395 porridge Nutrition 0.000 claims abstract description 75
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 68
- 235000009566 rice Nutrition 0.000 claims abstract description 68
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 48
- 235000013312 flour Nutrition 0.000 claims abstract description 42
- 241000894006 Bacteria Species 0.000 claims abstract description 24
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 24
- 239000004310 lactic acid Substances 0.000 claims abstract description 24
- 235000013336 milk Nutrition 0.000 claims abstract description 22
- 239000008267 milk Substances 0.000 claims abstract description 22
- 210000004080 milk Anatomy 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 241000194017 Streptococcus Species 0.000 claims abstract description 10
- 102000004139 alpha-Amylases Human genes 0.000 claims abstract description 10
- 108090000637 alpha-Amylases Proteins 0.000 claims abstract description 10
- 229940024171 alpha-amylase Drugs 0.000 claims abstract description 10
- 241000186660 Lactobacillus Species 0.000 claims abstract description 7
- 229940039696 lactobacillus Drugs 0.000 claims abstract description 7
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 5
- 241000209094 Oryza Species 0.000 claims description 67
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 18
- 235000000832 Ayote Nutrition 0.000 claims description 17
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 17
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 17
- 235000015136 pumpkin Nutrition 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 241000371652 Curvularia clavata Species 0.000 claims description 15
- 235000009508 confectionery Nutrition 0.000 claims description 14
- 239000008213 purified water Substances 0.000 claims description 9
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 5
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 5
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 5
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims description 5
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 5
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 240000001980 Cucurbita pepo Species 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 2
- 240000007594 Oryza sativa Species 0.000 abstract 1
- 240000004244 Cucurbita moschata Species 0.000 description 15
- 238000000855 fermentation Methods 0.000 description 14
- 230000004151 fermentation Effects 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 11
- 230000002292 Radical scavenging effect Effects 0.000 description 10
- 230000003078 antioxidant effect Effects 0.000 description 10
- 235000001014 amino acid Nutrition 0.000 description 9
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 150000004665 fatty acids Chemical class 0.000 description 9
- 150000001413 amino acids Chemical class 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 229930003935 flavonoid Natural products 0.000 description 8
- 150000002215 flavonoids Chemical class 0.000 description 8
- 235000017173 flavonoids Nutrition 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- 239000000523 sample Substances 0.000 description 8
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 150000003254 radicals Chemical group 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 4
- 208000030159 metabolic disease Diseases 0.000 description 4
- 238000003801 milling Methods 0.000 description 4
- XEZVDURJDFGERA-UHFFFAOYSA-N tricosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)=O XEZVDURJDFGERA-UHFFFAOYSA-N 0.000 description 4
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 3
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 3
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 3
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 3
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 3
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003579 anti-obesity Effects 0.000 description 3
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical class [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 235000019985 fermented beverage Nutrition 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- CKDDRHZIAZRDBW-UHFFFAOYSA-N henicosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCC(O)=O CKDDRHZIAZRDBW-UHFFFAOYSA-N 0.000 description 3
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 229960003104 ornithine Drugs 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 235000005875 quercetin Nutrition 0.000 description 3
- 229960001285 quercetin Drugs 0.000 description 3
- XSXIVVZCUAHUJO-HZJYTTRNSA-N (11Z,14Z)-icosadienoic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-HZJYTTRNSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- -1 GABA amino acids Chemical class 0.000 description 2
- XSXIVVZCUAHUJO-UHFFFAOYSA-N Homo-gamma-linoleic acid Natural products CCCCCC=CCC=CCCCCCCCCCC(O)=O XSXIVVZCUAHUJO-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 208000016097 disease of metabolism Diseases 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-AVQMFFATSA-N linoelaidic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-AVQMFFATSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- ZMKDEQUXYDZSNN-UHFFFAOYSA-N linolelaidic acid Natural products CCCCCCCCC=CCC=CCCCCC(O)=O ZMKDEQUXYDZSNN-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229940012843 omega-3 fatty acid Drugs 0.000 description 2
- 239000006014 omega-3 oil Substances 0.000 description 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 2
- 229940033080 omega-6 fatty acid Drugs 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- 230000036560 skin regeneration Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000010421 standard material Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- JDHILDINMRGULE-LURJTMIESA-N N(pros)-methyl-L-histidine Chemical compound CN1C=NC=C1C[C@H](N)C(O)=O JDHILDINMRGULE-LURJTMIESA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000062793 Sorghum vulgare Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000002554 disease preventive effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000019713 millet Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- YLLIGHVCTUPGEH-UHFFFAOYSA-M potassium;ethanol;hydroxide Chemical compound [OH-].[K+].CCO YLLIGHVCTUPGEH-UHFFFAOYSA-M 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C3/00—Preservation of milk or milk preparations
- A23C3/02—Preservation of milk or milk preparations by heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/127—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss
- A23C9/1275—Fermented milk preparations; Treatment using microorganisms or enzymes using microorganisms of the genus lactobacteriaceae and other microorganisms or enzymes, e.g. kefir, koumiss using only lactobacteriaceae for fermentation in combination with enzyme treatment of the milk product; using enzyme treated milk products for fermentation with lactobacteriaceae
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/133—Fruit or vegetables
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/104—Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
-
- A23Y2220/00—
-
- A23Y2300/00—
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
Abstract
본 발명은 타락죽을 포함하는 요거트의 제조방법에 관한 것으로, 쌀가루를 우유와 혼합한 혼합물에 열을 가하여 호화된 타락죽을 수득하는 단계; 상기 호화된 타락죽에 알파-아밀라아제를 첨가하여 당화된 타락죽을 수득하는 단계; 상기 당화된 타락죽에 스트렙토코코스속(Streptococcus), 락토바실러스속(Lactobacillus) 및 비피도박테리움속(Bifidobacterium) 으로 이루어진 군에서 선택된 적어도 하나의 유산균을 첨가하여 20 내지 60℃에서 발효시키는 단계;를 포함함으로써 원재료인 타락죽이나 유산균의 기능성을 유지하면서 품질이 우수한 요거트를 제조할 수 있다.The present invention relates to a method for producing yogurt containing tarak porridge, comprising the steps of applying heat to a mixture of rice flour and milk to obtain luxurious tarak porridge; Obtaining saccharified tarak porridge by adding alpha-amylase to the gelatinized tarak porridge; Adding at least one lactic acid bacteria selected from the group consisting of Streptococcus , Lactobacillus and Bifidobacterium to the saccharified tak porridge and fermenting at 20 to 60 ° C; By including, high-quality yogurt can be prepared while maintaining the functionality of tak porridge or lactic acid bacteria as raw materials.
Description
본 발명은 타락죽을 포함하는 요거트의 제조방법에 관한 것이다.The present invention relates to a method for producing yogurt containing tarak porridge.
쌀은 우리나라에서 예로부터 주식으로 이용되어 왔으며, 쌀의 영양성분은 도정 상태에 따라 다소 차이가 있으나 수분 15.5%일 때 백미의 경우 탄수화물 75.5%, 단백질 6.8%, 지질 1.3%, 회분 0.3%, 조섬유 0.3% 등으로 구성되며, 그외에 무기질 성분 인, 칼슘, 철분 등과 인체에 중요한 비타민 성분 타이민, 리보플라빈, 비타민 E, 니아신 등을 함유하고 있다. 최근 쌀 소비 촉진을 위한 다양한 품종의 기능성 쌀이 생산되어 소비되고 있다. 특수미 형태의 흑미는 항산화 기능이 우수한 anthicyanin계 자색 색소를 함유하고 있으며, 그 주성분은 cyanidin-3-glucoside으로 알려져 있다. 흑미는 무기질과 단백질 함량이 높으며, 항산화효과, NDA 손상 억제와 항암효과가 있으며 찰기와 독특한 향과 색으로 식생활에 다양하게 활용되고 있다.Rice has been used as a staple food in Korea since ancient times, and the nutritional components of rice vary somewhat depending on the state of milling, but when the moisture content is 15.5%, white rice contains 75.5% carbohydrates, 6.8% protein, 1.3% lipid, ash 0.3%, and 0.3% crude fiber. Recently, various varieties of functional rice have been produced and consumed to promote rice consumption. Black rice in the form of special rice contains anthicyanin purple pigment with excellent antioxidant function, and its main component is known as cyanidin-3-glucoside. Black rice is high in minerals and protein, has antioxidant effects, NDA damage inhibition, and anticancer effects, and is widely used in dietary life due to its sticky texture and unique flavor and color.
단호박은 서양계 호박으로 맛도 좋으며, 진황색을 띤 과육은 재래호박에 비하여 치밀하고 당도가 높으며, β-carotene을 비롯한 비타민류, 무기질, 식이섬유소가 풍부하며 항산화 및 항암효과가 있는 것으로 알려졌다.Sweet pumpkin is a Western pumpkin with good taste, dark yellow flesh is denser and has higher sugar content than conventional pumpkin, and is rich in vitamins, minerals, and dietary fiber including β-carotene, and is known to have antioxidant and anticancer effects.
한국의 전통 궁중음식인 타락죽은 낙죽 혹은 우유죽이라 하며, 이는 우유와 멥쌀을 이용하여 만든 죽으로 어린이, 노인, 환자에게 좋은 영양식으로 알려져 왔다. 한의학에서는 치료를 목적으로 하는 탕재와는 달리 예로부터 병을 예방하는 차원에서 한약재와 쌀, 좁쌀 등의 곡류를 이용한 약죽을 권하였다. 재료를 손쉽게 구할 수 있고, 조리법도 간단하지만, 타락죽을 이용한 가공식품을 개발하여 대중화를 시도한 연구는 미미하다. 최근 들어 건강에 대한 관심이 고조되면서 기능성이 강조된 발효음료가 새롭게 각광을 받고 있다. 최근 요거트의 발효 기질의 일부로 쌀, 보리, 옥수수 등과 같은 곡류, 대두, 고구마, 호박 등에 이용하고 있으나, 타락죽을 이용한 발효음료의 개발은 부족한 편이다.Tarakjuk, a traditional Korean court food, is called nakjuk or milk porridge. In oriental medicine, unlike tangjae for the purpose of treatment, medicinal porridge using herbal medicines and grains such as rice and millet has been recommended to prevent diseases since ancient times. Ingredients are easily available and the recipe is simple, but researches that have tried to develop and popularize processed food using tarak porridge are insignificant. Recently, as interest in health has increased, fermented beverages with emphasis on functionality are newly in the limelight. Recently, grains such as rice, barley, corn, etc., soybeans, sweet potatoes, pumpkins, etc. have been used as part of the fermentation substrate of yogurt, but the development of fermented beverages using tarak porridge is lacking.
최근 식생활의 다양화, 고급화가 이루어짐에 따라 요거트가 카페뿐 아니라 완제품 포장형태가 시장에서 판매되어 그 소비가 늘고 있는 실정이다. 현대인의 생활방식과 식생활의 변화, 질병 형태의 다양화 등 여러 사회적 여건의 변화로 현대인의 건강에 대한 관심 증가로 균형식이 요구되고 있으며 이는 발효음료에서도 설탕 함량을 줄이고 기능성이 우수하면서 개운한 맛을 낼 수 있는 재료를 선택하는 경향이 두드러지게 나타나고 있다.Recently, with the diversification and gentrification of dietary life, yogurt is sold not only in cafes but also in the market for finished product packaging, and its consumption is increasing. Due to changes in various social conditions, such as lifestyle and dietary changes of modern people and diversification of disease types, modern people's interest in health is increasing, and a balanced diet is required. In fermented beverages, there is a noticeable tendency to select ingredients that can reduce sugar content and have excellent functionality and a refreshing taste.
본 발명은 타락죽을 포함하는 요거트의 제조방법을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a method for producing yogurt containing tarak porridge.
본 발명은 타락죽을 포함하는 요거트를 제공하는 것을 목적으로 한다.An object of the present invention is to provide yogurt containing tarak porridge.
1. 쌀가루와 우유의 혼합물에 열을 가하여 호화된 타락죽을 수득하는 단계;1. Applying heat to a mixture of rice flour and milk to obtain luxurious tarak porridge;
상기 호화된 타락죽에 알파-아밀라아제를 첨가하여 당화된 타락죽을 수득하는 단계;Obtaining saccharified tarak porridge by adding alpha-amylase to the gelatinized tarak porridge;
상기 당화된 타락죽에 스트렙토코코스속(Streptococcus), 락토바실러스속(Lactobacillus) 및 비피도박테리움속(Bifidobacterium) 으로 이루어진 군에서 선택된 적어도 하나의 유산균을 첨가하여 20 내지 60℃에서 발효시키는 단계;를 포함하는 타락죽을 포함하는 요거트의 제조방법.Adding at least one lactic acid bacterium selected from the group consisting of Streptococcus , Lactobacillus and Bifidobacterium to the saccharified tark porridge and fermenting at 20 to 60 ° C. Method for producing yogurt containing tark porridge.
2. 위 1에 있어서, 상기 쌀가루는 흑미가루 또는 백미가루로 이루어진 군에서 선택된 적어도 하나인, 타락죽을 포함하는 요거트의 제조방법.2. In the above 1, wherein the rice flour is at least one selected from the group consisting of black rice flour or white rice flour, method of producing yogurt containing tarak porridge.
3. 위 1에 있어서, 상기 쌀가루는 쌀 100 중량부를 15 내지 30℃에서 정제수 300 내지 500 중량부에 침지시키고 5 내지 20시간 후 상기 정제수를 제거한 후, 분쇄하여 수득된 것인, 타락죽을 포함하는 요거트의 제조방법.3. In the above 1, the rice flour is obtained by immersing 100 parts by weight of rice in 300 to 500 parts by weight of purified water at 15 to 30 ° C., removing the purified water after 5 to 20 hours, and then pulverizing. Method for producing yogurt.
4. 위 1에 있어서, 상기 열을 가하기 전에 상기 혼합물에 단호박을 더 첨가하는, 타락죽을 포함하는 요거트의 제조방법.4. The method of producing yogurt containing tarak porridge according to 1 above, wherein sweet pumpkin is further added to the mixture before applying the heat.
5. 위 1에 있어서, 상기 우유는 오메가-3 및 오메가-6을 1:3 내지 1:5의 중량비로 포함하는, 타락죽을 포함하는 요거트의 제조방법.5. The method according to 1 above, wherein the milk contains omega-3 and omega-6 in a weight ratio of 1:3 to 1:5.
6. 위 1에 있어서, 상기 유산균은 스트렙토코코스 서모필러스(Streptococcus thermophiles), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 락토바실러스 델브우에키이 불가리쿠스(Lactobacillus delbrueckii ssp. bulgaricus) 및 비피도박테리움 애니멀리스 락티스(Bifidobacterium animalis ssp. lactis)인, 타락죽을 포함하는 요거트의 제조방법.6. In the above 1, the lactic acid bacteria are Streptococcus thermophiles, Lactobacillus acidophilus , Lactobacillus delbrueckii ssp. bulgaricus and Bifidobacterium animalis ssp. lactis Method for producing yogurt containing phosphorus and tarak porridge.
7. 위 1에 있어서, 상기 요거트는 오메가-3 및 오메가-6을 1:3 내지 1:5의 중량비로 포함하는, 타락죽을 포함하는 요거트의 제조방법.7. In the above 1, wherein the yogurt comprises omega-3 and omega-6 in a weight ratio of 1: 3 to 1: 5, the method of producing yogurt containing tarak porridge.
8. 위 1 내지 7 중 어느 한 항의 제조방법으로 제조된 타락죽을 포함하는 요거트.8. Yogurt containing tarak porridge prepared by any one of the above 1 to 7 manufacturing methods.
본 발명의 제조방법은 최적의 조건을 갖는 단계를 거침으로써 원재료인 타락죽이나 유산균의 기능성을 유지하면서 품질이 우수한 요거트를 제조할 수 있다.The manufacturing method of the present invention can produce yogurt with excellent quality while maintaining the functionality of tarak porridge or lactic acid bacteria, which are raw materials, by going through steps with optimal conditions.
본 발명의 요거트는 타락죽을 이용해 제조됨으로써 우수한 관능성 및 기능성을 나타낼 수 있고, 식품 개발에 적절히 이용될 수 있다.The yogurt of the present invention can exhibit excellent functionality and functionality by being prepared using tarak porridge, and can be appropriately used for food development.
도 1은 일 실시예에 따른 백미가 포함된 타락죽을 이용한 요거트의 제조 과정을 나타낸다.
도 2는 일 실시예에 따른 흑미가 포함된 타락죽을 이용한 요거트의 제조 과정을 나타낸다.
도 3은 일 실시예에 따른 단호박이 포함된 타락죽을 이용한 요거트의 제조 과정을 나타낸다.
도 4는 일 실시예에 따른 타락죽을 포함하는 요거트의 제조방법을 나타낸 그림이다.1 shows a manufacturing process of yogurt using tarak porridge containing white rice according to an embodiment.
2 shows a manufacturing process of yogurt using tarak porridge containing black rice according to an embodiment.
Figure 3 shows a manufacturing process of yogurt using tarak porridge containing sweet pumpkin according to an embodiment.
4 is a diagram showing a method of manufacturing yogurt including tarak porridge according to an embodiment.
본 발명은 쌀가루와 우유의 혼합물에 열을 가하여 호화된 타락죽을 수득하는 단계(S100); 상기 호화된 타락죽에 알파-아밀라아제를 첨가하여 당화된 타락죽을 수득하는 단계(S200); 상기 당화된 타락죽에 스트렙토코코스속(Streptococcus), 락토바실러스속(Lactobacillus) 및 비피도박테리움속(Bifidobacterium) 으로 이루어진 군에서 선택된 적어도 하나의 유산균을 첨가하여 20 내지 60℃에서 발효시키는 단계(S300);를 포함하는 타락죽을 포함하는 요거트의 제조방법을 제공한다.The present invention comprises the steps of applying heat to a mixture of rice flour and milk to obtain a luxurious tarak porridge (S100); Adding alpha-amylase to the gelatinized tarak porridge to obtain saccharified tarak porridge (S200); Adding at least one lactic acid bacterium selected from the group consisting of Streptococcus , Lactobacillus and Bifidobacterium to the saccharified tak porridge and fermenting at 20 to 60 ° C. (S300); It provides a method for producing yogurt including tak porridge.
용어 “타락죽(駝酪粥)”은 쌀가루를 우유와 섞어 끓인 죽을 의미하며, 우유죽으로도 표현된다.The term “tarakjuk(駝酪粥)” means porridge made by mixing rice flour with milk and is also expressed as milk porridge.
용어 “쌀가루”는 쌀을 갈거나 빻아서 만든 가루를 의미하며, 쌀의 종류에 따라 백미가루, 흑미가루 또는 찹쌀가루일 수 있으나, 이에 제한되지 않는다.The term "rice flour" refers to powder made by grinding or grinding rice, and may be white rice flour, black rice flour, or glutinous rice flour depending on the type of rice, but is not limited thereto.
호화된 타락죽을 수득하는 단계(S100)에서 쌀가루는 흑미가루 또는 백미가루로 이루어진 군에서 선택된 적어도 하나일 수 있다. 백미가루는 백미 멥쌀가루 또는 백미 찹쌀가루일 수 있다.In the step of obtaining luxury tarak porridge (S100), the rice flour may be at least one selected from the group consisting of black rice flour and white rice flour. The white rice flour may be white rice nonglutinous rice flour or white rice glutinous rice flour.
일 실시예에 따르면 상기 쌀가루는 백미가루일 수 있고, 이 때 제조된 요거트는 순백미 요거트일 수 있다. 일 실시예에 따르면 상기 쌀가루는 흑미가루일 수 있고, 이 때 제조된 요거트는 흑미 요거트일 수 있다.According to one embodiment, the rice flour may be white rice flour, and the yogurt prepared at this time may be pure white rice yogurt. According to one embodiment, the rice flour may be black rice flour, and the yogurt prepared in this case may be black rice yogurt.
호화된 타락죽을 수득하는 단계(S100)에서 쌀가루는 구매된 것이거나 제조된 것일 수 있다.In the step of obtaining luxury tarak porridge (S100), rice flour may be purchased or manufactured.
호화된 타락죽을 수득하는 단계(S100)에서 사용된 쌀가루는 쌀을 15 내지 30℃에서 물(예컨대 정제수)에 5 내지 20시간 동안 침지시킨 후, 상기 물을 제거하여 얻은 여과물을 분쇄하여 제조된 것일 수 있다. 구체적으로 쌀가루는 쌀가루는 쌀 100 중량부를 15 내지 30℃에서 물 300 내지 500 중량부에 침지시키고 5 내지 20시간 후 상기 정제수를 제거한 후 분쇄하여 수득된 것일 수 있다.The rice flour used in the step (S100) of obtaining luxury tarak porridge may be prepared by immersing rice in water (eg, purified water) at 15 to 30 ° C. for 5 to 20 hours, and then pulverizing the filtrate obtained by removing the water. Specifically, rice flour may be obtained by immersing 100 parts by weight of rice in 300 to 500 parts by weight of water at 15 to 30 ° C., removing the purified water after 5 to 20 hours, and then grinding.
일 실시예에 따르면, 쌀가루는 백미를 흐르는 물에 수세하고, 약 20℃의 실온에서 백미의 4배수에 해당하는 정제수에서 8시간 동안 침지한 다음, 체에 받쳐 수분을 제거하고, 쌀 제분기에 2회 제분과정을 거친 후 20 mesh 체에 내려 수득한 것일 수 있다. 일 실시예에 따르면, 쌀가루는 흑미를 흐르는 물에 수세하고, 약 20℃의 실온에서 흑미의 4배수에 해당하는 정제수에서 12시간 동안 침지한 다음, 체에 받쳐 수분을 제거하고, 쌀 제분기에 2회 제분과정을 거친 후 20 mesh 체에 내려 수득한 것일 수 있다.According to one embodiment, rice flour is obtained by washing white rice with running water, immersing it in purified water corresponding to four times the amount of white rice at room temperature of about 20 ° C. for 8 hours, removing moisture by sieving, and then going through a milling process twice in a rice mill and then sifting through a 20 mesh sieve. According to one embodiment, rice flour is obtained by washing black rice with running water, immersing it in purified water corresponding to four times the amount of black rice at room temperature of about 20 ° C. for 12 hours, sieving to remove moisture, and then going through a milling process twice in a rice mill and then sifting through a 20 mesh sieve.
호화된 타락죽을 수득하는 단계(S100)에서 상기 열을 가하기 전에 상기 혼합물에 단호박을 더 첨가할 수 있다. 일 실시예에 따르면 상기 쌀가루는 백미가루일 수 있고, 상기 열을 가하기 전에 상기 혼합물에 단호박을 더 첨가할 수 있다. 이 경우 제조된 요거트는 단호박 요거트일 수 있다.In the step of obtaining luxury tarak porridge (S100), sweet pumpkin may be further added to the mixture before applying the heat. According to one embodiment, the rice flour may be white rice flour, and sweet pumpkin may be further added to the mixture before applying the heat. In this case, the manufactured yogurt may be sweet pumpkin yogurt.
호화된 타락죽을 수득하는 단계(S100)에서 상기 우유는 오메가-3 및 오메가-6을 포함하는 우유일 수 있다. 구체적으로 상기 우유는 오메가-3와 상기 오메가-6를 1: 3 내지 5, 또는 1:4의 중량비로 포함하는 것일 수 있다.In the step (S100) of obtaining luxury tarak porridge, the milk may be milk containing omega-3 and omega-6. Specifically, the milk may contain omega-3 and omega-6 in a weight ratio of 1:3 to 5, or 1:4.
호화된 타락죽을 수득하는 단계(S100)에서 쌀가루를 우유와 혼합한 혼합물을 사용함으로써 최종 생산된 요거트의 식감이 부드러워질 수 있다.In the step of obtaining luxurious tarak porridge (S100), the texture of the finally produced yogurt can be softened by using a mixture of rice flour and milk.
당화된 타락죽을 수득하는 단계(S200)는 상기 호화된 타락죽이 30 내지 70℃, 40 내지 60℃, 또는 45 내지 55℃에 도달할 때 알파-아밀라아제를 첨가하는 것일 수 있다. 위와 같은 온도범위를 벗어나는 경우 타락죽의 당화 효율이 떨어질 수 있다.The step of obtaining saccharified tarak porridge (S200) may be adding alpha-amylase when the gelatinized tarak porridge reaches 30 to 70 ° C, 40 to 60 ° C, or 45 to 55 ° C. If the temperature is out of the above range, the saccharification efficiency of tarak porridge may decrease.
당화된 타락죽을 수득하는 단계(S200)에서 사용되는 알파-아밀라아제는 그 형태가 제한되지 않으며, 예컨대 액체일 수 있다.Alpha-amylase used in the step of obtaining saccharified tarak porridge (S200) is not limited in its form, and may be, for example, liquid.
발효시키는 단계(S300)는 상기 당화된 타락죽에 유산균을 첨가하여 발효시키는 것일 수 있다.The fermentation step (S300) may be to ferment by adding lactic acid bacteria to the saccharified tarak porridge.
발효시키는 단계(S300)에서 사용된 유산균은 락토코커스속(Lactococcus), 스트렙토코코스속(Streptococcus), 락토바실러스속(Lactobacillus), 비피도박테리움속(Bifidobacterium) 및 페디오코커스속(Pediococcus)으로 이루어진 군에서 선택된 적어도 하나일 수 있으나, 이에 제한되지 않는다.The lactic acid bacteria used in the fermentation step (S300) may be at least one selected from the group consisting of Lactococcus , Streptococcus , Lactobacillus , Bifidobacterium and Pediococcus , but is not limited thereto.
유산균은 스트렙토코코스 서모필러스(Streptococcus thermophiles), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 락토바실러스 델브우에키이 불가리쿠스(Lactobacillus delbrueckii ssp. bulgaricus) 및 비피도박테리움 애니멀리스 락티스(Bifidobacterium animalis ssp. lactis)로 이루어진 군에서 선택된 적어도 하나일 수 있다.The lactic acid bacteria may be at least one selected from the group consisting of Streptococcus thermophiles, Lactobacillus acidophilus, Lactobacillus delbrueckii ssp. bulgaricus , and Bifidobacterium animalis ssp. lactis . .
일 실시예에 따르면, 유산균은 스트렙토코코스 서모필러스(Streptococcus thermophiles), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 락토바실러스 델브우에키이 불가리쿠스(Lactobacillus delbrueckii ssp. bulgaricus) 및 비피도박테리움 애니멀리스 락티스(Bifidobacterium animalis ssp. lactis)의 조합일 수 있다.According to one embodiment, the lactic acid bacteria may be a combination of Streptococcus thermophiles, Lactobacillus acidophilus, Lactobacillus delbrueckii ssp. bulgaricus and Bifidobacterium animalis ssp. lactis there is
발효시키는 단계(S300)에서 사용된 유산균은 동결건조된 유산균일 수 있다. 일 실시예에 따르면, 발효시키는 단계(S300)에서 사용된 유산균은 시판 제품인 사코 동결건조 요거트 유산균에 포함된 것일 수 있다.The lactic acid bacteria used in the fermentation step (S300) may be freeze-dried lactic acid bacteria. According to one embodiment, the lactic acid bacteria used in the fermentation step (S300) may be included in the commercially available Sarco freeze-dried yogurt lactic acid bacteria.
발효시키는 단계(S300)에서 발효 온도는 20 내지 60℃, 30 내지 50℃, 35 내지 45℃일 수 있으나, 이에 제한되지 않는다.In the fermentation step (S300), the fermentation temperature may be 20 to 60 ° C, 30 to 50 ° C, or 35 to 45 ° C, but is not limited thereto.
발효시키는 단계(S300)에서 발효 시간은 1 내지 10시간, 2 내지 9시간, 3 내지 8시간, 4 내지 7시간 또는 5 내지 6시간일 수 있으나, 이에 제한되지 않는다.The fermentation time in the fermentation step (S300) may be 1 to 10 hours, 2 to 9 hours, 3 to 8 hours, 4 to 7 hours, or 5 to 6 hours, but is not limited thereto.
본 발명의 제조방법으로 제조된 타락죽을 포함하는 요거트는 오메가-3 및 오메가-6를 포함할 수 있다. 구체적으로, 요거트는 오메가-3 및 오메가-6을 1:3 내지 1:5 중량비, 또는 1:4의 중량비로 포함하는 것일 수 있다.Yogurt containing tarak porridge prepared by the manufacturing method of the present invention may contain omega-3 and omega-6. Specifically, yogurt may contain omega-3 and omega-6 in a weight ratio of 1:3 to 1:5 or 1:4.
본 발명의 제조방법으로 제조된 타락죽을 포함하는 요거트는 열처리, 발효 등의 가공과정을 거치더라도, 제조과정에서 사용된 재료인 우유에 포함된 오메가-3 및 오메가-6의 비율을 그대로 유지할 수 있다.Yogurt containing tarak porridge prepared by the manufacturing method of the present invention can maintain the ratio of omega-3 and omega-6 contained in milk, which is a material used in the manufacturing process, even if it undergoes processing such as heat treatment and fermentation.
본 발명의 제조방법으로 제조된 타락죽을 포함하는 요거트는 오메가-3 및 오메가-6의 비율을 1:3 내지 1:5 중량비, 또는 1:4의 중량비로 포함함으로써 우수한 기능성(예컨대 대사성 질환 예방 또는 개선 효과)을 나타낼 수 있는 것과 동시에, 우유를 섭취하기 어려워하는 소비자들에게 높은 기호도를 나타낼 수 있다. 오메가-3 및 오메가-6가 적절한 비율로 밸런스를 유지하는 경우, 심혈관계 질환을 비롯한 대사성 질환에 대한 예방 또는 개선 효과를 나타낼 수 있다.Yoghurt containing tarak porridge prepared by the manufacturing method of the present invention has excellent functionality (eg, metabolic disease prevention or improvement effect) by including the ratio of omega-3 and omega-6 at a weight ratio of 1:3 to 1:5, or 1:4, and at the same time, it can exhibit high preference for consumers who have difficulty in eating milk. When omega-3 and omega-6 are balanced in an appropriate ratio, it can prevent or improve metabolic diseases including cardiovascular diseases.
본 발명의 제조방법으로 제조된 타락죽을 포함하는 요거트는 대사성 질환의 예방 또는 개선 효과를 나타낼 수 있다. 예컨대, 대사성 질환은 심혈관계 질환 및/또는 제2형 당뇨병일 수 있으나, 이에 제한되지 않는다.Yogurt containing tarak porridge prepared by the production method of the present invention may exhibit an effect of preventing or improving metabolic diseases. For example, the metabolic disease may be cardiovascular disease and/or type 2 diabetes, but is not limited thereto.
또한, 본 발명은 전술한 제조방법으로 제조된 타락죽을 포함하는 요거트를 제공한다. 타락죽과 요거트에 대한 내용은 전술한 바 있어, 구체적인 설명은 생략한다.In addition, the present invention provides a yogurt comprising tarak porridge prepared by the above-described manufacturing method. The contents of tarak porridge and yogurt have been described above, and a detailed description is omitted.
본 발명의 요거트는 심혈관계 질환의 예방과 관련된 지방산등을 포함하며, 특히 오메가-3 및 오메가-6을 적절한 비율로 포함하고, 뇌혈류 촉진 및 신경안정 효과를 나타낼 수 있는 GABA 아미노산을 포함하며, 근육 합성 증가 효과, 기초대사를 촉진 효과, 체지방 대사 효과, 항비만 효과, 면역증강 효과, 간보호 효과, 스트레스 완화 효과, 피부 재생 효과 등을 나타내는 것으로 알려진 오르니틴(ornithine)을 포함하며, 항산화 활성을 나타낼 수 있다.The yogurt of the present invention contains fatty acids related to the prevention of cardiovascular diseases, and in particular, contains omega-3 and omega-6 in an appropriate ratio, contains GABA amino acids capable of promoting cerebral blood flow and stabilizing nerves, and increases muscle synthesis. It contains ornithine, which is known to exhibit an anti-obesity effect, an immune enhancing effect, a liver protecting effect, a stress relieving effect, a skin regeneration effect, and the like, and may exhibit antioxidant activity.
이처럼 본 발명의 요거트는 우수한 기능성을 나타내며, 동시에 섭취의 편의성 및 우수한 맛을 나타낼 수 있다. 또한, 위와 같이 우수한 기능성을 나타내는 본 발명의 요거트는 우유를 섭취하기 어려운 소비자들로부터 높은 수요도가 나타날 것이다.As such, the yogurt of the present invention exhibits excellent functionality, and at the same time, it can exhibit convenience of intake and excellent taste. In addition, the yogurt of the present invention, which exhibits excellent functionality as described above, will show high demand from consumers who have difficulty consuming milk.
이하, 실시예를 들어 본 발명의 구성 및 효과를 보다 구체적으로 설명한다. 그러나 아래 실시예는 본 발명에 대한 이해를 돕기 위해 예시의 목적으로만 제공된 것일 뿐 본 발명의 범주 및 범위가 그에 의해 제한되는 것은 아니다.Hereinafter, the configuration and effects of the present invention will be described in more detail by way of examples. However, the following examples are provided only for illustrative purposes to aid understanding of the present invention, and the scope and scope of the present invention are not limited thereto.
1. 타락죽을 이용한 요거트의 제조1. Manufacture of yogurt using tarak porridge
본 발명자들은 (1) 백미 또는 흑미를 분쇄해 쌀가루를 제조하는 단계, (2) 쌀가루에 우유를 첨가하고 열처리하여 호화된 타락죽을 제조하는 단계, (3) 호화된 타락죽에 당화 효소인 알파-아밀라아제를 첨가하여 당화시키는 단계, (4) 당화된 타락죽에 유산균을 첨가하고 발효시키는 단계를 거쳐 요거트(실시예 1 내지 3)를 제조하였다. 요거트 제조시 사용된 재료들의 함량을 표 1에 나타내었다. 각 실시예들의 보다 구체적인 제조방법은 아래에 기재하였다.The inventors of the present invention (1) preparing rice flour by grinding white or black rice, (2) adding milk to rice flour and heat-treating it to prepare a luxurious tarak porridge, (3) adding a saccharification enzyme, alpha-amylase to the gelatinized tark porridge, saccharifying it, (4) preparing yogurt (Examples 1 to 3) through the steps of adding lactic acid bacteria to the saccharified tark porridge and fermenting it. Table 1 shows the contents of ingredients used in yogurt production. More specific manufacturing methods of each embodiment are described below.
(1) 실시예 1 (1) Example 1
1) 쌀가루 제조 단계: 흐르는 물에서 백미(맵쌀)을 3회 수세하여 약 20℃의 실온에서 백미의 4배수에 해당하는 정제수에서 8시간 동안 침지한 다음, 체에 받쳐 수분을 제거하였다. 그 후 쌀 제분기로 2회 제분과정을 거친 후 20 mesh 체에 내려 백미가루를 제조하였다.1) Rice flour preparation step: polished rice (spicy rice) was washed with running water three times, immersed in purified water four times the amount of white rice at room temperature of about 20 ° C. for 8 hours, and then sieved to remove moisture. After that, after going through the milling process twice with a rice mill, it was put down through a 20 mesh sieve to prepare white rice powder.
2) 호화된 타락죽 제조 단계: 제조된 백미가루 90g에 우유 900g(오메가밸런스 우유, 그린그래스)을 첨가하고, 나무주걱으로 잘 풀어주면서 30분 정도 쌀가루를 불렸다. 그 후 중약불에서 저어가며 농도가 걸쭉해지도록 호화시켜 타락죽을 제조하였다.2) Luxurious tarak porridge manufacturing step: 900 g of milk (omega balance milk, green grass) was added to 90 g of white rice powder, and the rice flour was soaked for about 30 minutes while mixing well with a wooden spatula. After that, while stirring over medium-low heat, the consistency was thickened to make tarak porridge.
3) 당화된 타락죽 제조 단계: 호화된 타락죽이 약 50℃에 도달하였을 때 액체 알파-아밀라아제를 0.2g 첨가하고 약 3-10분동안 저어 묽은 당화액을 제조하였다.3) Saccharified tarak porridge preparation step: When the gelatinized tarak porridge reached about 50° C., 0.2 g of liquid alpha-amylase was added and stirred for about 3-10 minutes to prepare a thin saccharified liquid.
4) 유산균 발효 단계: 액화와 당화된 타락죽이 40℃가 되었을 때 유산균(사코 동결건조 요거트 유산균)을 0.4g 첨가하고 잘 저은 후, 유리병에 담아 40℃ 발효실 5-6시간 정도 유산균 발효시켜 요거트(실시예 1, 순백미 요거트)를 수득하고, 냉장 보관하였다. 타락죽에 첨가된 유산균은 스트렙토코코스 서모필러스(Streptococcus thermophiles), 락토바실러스 아시도필루스(Lactobacillus acidophilus), 락토바실러스 델브우에키이 불가리쿠스(Lactobacillus delbrueckii ssp. bulgaricus) 및 비피도박테리움 애니멀리스 락티스(Bifidobacterium animalis ssp. lactis)이다.4) Lactic acid bacteria fermentation step: When the liquefied and saccharified tarak porridge reached 40 ° C, 0.4 g of lactic acid bacteria (Sako freeze-dried yogurt lactobacillus) was added, stirred well, and then put in a glass bottle and 40 ° C. The lactic acid bacteria added to tarak porridge are Streptococcus thermophiles, Lactobacillus acidophilus , Lactobacillus delbrueckii ssp. bulgaricus , and Bifidobacterium animalis ssp. lactis .
(2) 실시예 2(2) Example 2
실시예 1의 제조방법과 동일하되, 1) 쌀가루 제조 단계에서 백미 대신 흑미를 사용하고 12시간 침지하였고, 3) 당화된 타락죽 제조 단계에서 알파-아밀라아제를 0.4g 첨가하였다. 또한 4) 유산균 발효 단계에서 유산균을 0.5g 첨가하여 요거트(실시예 2, 흑미 요거트)를 제조하였다. Same as the manufacturing method of Example 1, but 1) black rice was used instead of white rice in the rice flour manufacturing step and soaked for 12 hours, 3) 0.4 g of alpha-amylase was added in the saccharified tarak porridge manufacturing step. In addition, 4) yogurt (Example 2, black rice yogurt) was prepared by adding 0.5 g of lactic acid bacteria in the lactic acid bacteria fermentation step.
(3) 실시예 3(3) Example 3
실시예 1의 제조방법과 동일하되, 2) 호화된 타락죽 제조 단계에서 백미가루에 우유외에 찐 단호박도 함께 첨가하였고, 이때 백미가루를 20g, 단호박을 250g 사용하였다. 2) 호화된 타락죽 제조 단계에서 사용된 찐 단호박은 시판 단호박 제품을 구입하여 수세한 후, 세척된 단호박을 2-3등분한 다음 껍질 째 100℃에서 50분 정도 찐(steaming)후 껍질을 제거하고, 파쇄하여 20 mesh 체에 내려 제조하였다. 3) 당화된 타락죽 제조 단계에서 알파-아밀라아제를 0.5g 첨가하였다. 또한 4) 유산균 발효 단계에서 유산균을 0.5g 첨가하여 요거트(실시예 3, 단호박 요거트)를 제조하였다. It is the same as the manufacturing method of Example 1, but 2) in the step of manufacturing luxury tarak porridge, steamed sweet pumpkin was added to the white rice powder in addition to milk, and at this time, 20 g of white rice powder and 250 g of sweet pumpkin were used. 2) For the steamed sweet pumpkin used in the luxury tark porridge manufacturing step, a commercially available sweet pumpkin product was purchased, washed with water, and then the washed sweet pumpkin was divided into 2-3 parts, steamed at 100 ° C for about 50 minutes, and then the skin was removed. It was crushed and prepared by sifting through a 20 mesh sieve. 3) 0.5 g of alpha-amylase was added in the step of preparing saccharified tarak porridge. In addition, 4) 0.5 g of lactic acid bacteria was added in the lactic acid bacteria fermentation step to prepare yogurt (Example 3, sweet pumpkin yogurt).
2. 타락죽을 이용한 요거트의 영양성분 및 항산화 효과 측정2. Measurement of nutritional components and antioxidant effects of yogurt using tarak porridge
(1) 요거트의 지방산 측정(1) Measurement of fatty acids in yogurt
위 1.의 방법으로 제조된 3종의 요거트의 지방산 조성과 함량 분석을 아래와 같이 수행하였다. 지방산 분석은 요거트 시료 20 g을 ether로 추출·여과하여 감압·농축한 지방질 약 100 mg을 가지형 플라스크에 취하고 1 N KOH·ethanol 용액 4 mL를 섞어 유지 방울이 없어질 때까지 교반 시킨 후 14% BF 3 -ethanol 5 mL를 첨가하였다. 냉각기를 부착하여 80℃에서 5분간 가열하여 메틸에스터화하여 NaCl 포화용액 3 mL를 가하고, 다시 헥산 1 mL를 가하여 흔들어 섞은 후 시험관에 옮겨 정치하였다. 그 후 상층액을 취하여 무수 Na2SO4를 넣어 수분을 제거하고 가스 크로마토그래피(GC-17A, Shimadzu Co., Kyoto, Japan)로 분석하여 23종의 지방산을 분석하였다.The fatty acid composition and content analysis of the three types of yogurt prepared by the method of 1. above was performed as follows. For fatty acid analysis, 20 g of yogurt sample was extracted and filtered with ether, and about 100 mg of fat concentrated under reduced pressure was taken in an eggplant flask, mixed with 4 mL of 1 N KOH ethanol solution, stirred until oil droplets disappeared, and 5 mL of 14% BF 3 -ethanol was added. After attaching a cooler and heating at 80 ° C. for 5 minutes to methyl esterify, 3 mL of a saturated NaCl solution was added, and 1 mL of hexane was added, shaken, and then transferred to a test tube and allowed to stand. Thereafter, the supernatant was taken, anhydrous Na 2 SO 4 was added thereto to remove moisture, and 23 types of fatty acids were analyzed by gas chromatography (GC-17A, Shimadzu Co., Kyoto, Japan).
실시예 1 내지 3의 요거트 각각의 지방산 조성 및 오메가-3:오메가-6의 비율을 아래 표 2에 나타내었다. 아래 표 2에 나타난 것처럼 3종의 요거트 모두 심혈관계질환 예방과 관련된 단일 불포화지방산과 다가 불포화지방산을 함유하고 있었다. 단일 불포화지방산 중 심혈관계 질환 예방효과가 있는 것으로 알려진 oleic acid는 세 종류 요거트에 모두 함유되어 있으며, 높은 함량을 나타내었다. 다가 불포화지방산 중 오메가-6 지방산에 포함된 linoleic acid는 3 종의 요거트 모두에서 검출되었으나, linolelaidic acid는 실시예 2 및 3에서만 검출되었고, cis-11,14-eicosadienoic acid는 실시예 3에서만 검출되었다. 오메가-3 지방산에 포함된 linolenic acid는 3 종의 요거트 모두에서 검출되었으나, cis-5,8,11,14,17-eicosapentaenoic acid(EPA)는 실시예 1 및 3에서만 검출되었다. 실시예 1 내지 3에서 검출된 오메가-3:오메가-6 비율은 각각 순서대로 1:3.92, 1:3.83, 1:3.15로 확인되었다. 위 오메가-3:오메가-6 비율에서 확인된 것처럼, 본 발명의 제조방법으로 제조된 요거트는 제조과정에서 열처리, 당처리, 발효과정 등 다양한 가공처리가 되었음에도 불구하고 재료인 우유에 포함된 오메가-3:오메가-6 비율이 그대로 유지되는 것을 확인하였다.The fatty acid composition and omega-3:omega-6 ratio of each of the yogurts of Examples 1 to 3 are shown in Table 2 below. As shown in Table 2 below, all three types of yogurt contained monounsaturated fatty acids and polyunsaturated fatty acids related to cardiovascular disease prevention. Among monounsaturated fatty acids, oleic acid, which is known to have cardiovascular disease preventive effects, was contained in all three types of yogurt and showed a high content. Among polyunsaturated fatty acids, linoleic acid included in omega-6 fatty acids was detected in all three types of yogurt, but linolelaidic acid was detected only in Examples 2 and 3, and cis-11,14-eicosadienoic acid was detected only in Example 3. Linolenic acid included in omega-3 fatty acids was detected in all three types of yogurt, but cis-5,8,11,14,17-eicosapentaenoic acid (EPA) was detected only in Examples 1 and 3. The omega-3:omega-6 ratios detected in Examples 1 to 3 were confirmed to be 1:3.92, 1:3.83, and 1:3.15, respectively, in order. As confirmed in the above omega-3: omega-6 ratio, the yogurt produced by the manufacturing method of the present invention is omega-3 contained in milk, which is a material, despite various processing such as heat treatment, sugar treatment, and fermentation process. It was confirmed that the ratio of omega-6 was maintained.
(2) 요거트의 구성 아미노산 분석(2) Analysis of constituent amino acids of yogurt
분해관에 시료 0.5 g, 6 N HCl 3 mL를 계량하여 탈기하고 121℃에 24시간 가수분해한 다음 여액을 rotary vacuum evaporator(NVC-1100, Eyela Co., Tokyo, Japan)로 감압·농축하여, 소듐포스페이트버퍼(pH 7.0) 10 mL로 정용하였다. 용액 1 mL를 취하고 멤브레인 필터(0.2 μm)로 여과한 후 아미노산 자동분석기(S433-H, SYKAM, Eresing, Germany)로 분석하였다.0.5 g of the sample and 3 mL of 6 N HCl were weighed in a decomposition tube, degassed, and hydrolyzed at 121 ° C for 24 hours. 1 mL of the solution was taken, filtered through a membrane filter (0.2 μm), and analyzed with an automatic amino acid analyzer (S433-H, SYKAM, Eresing, Germany).
아래 표 3에 실시예 1 내지 3의 요거트 각각의 아미노산 조성 및 함량을 측정한 결과를 나타내었다. 실시예 1은 6종의 아미노산, 실시예 2는 7종의 아미노산, 실시예 3은 15종의 아미노산이 검출되었고, 총 아미노산 함량은 실시예 1부터 3까지 순서대로 15.67 mg%, 22.97 mg%, 109.95 mg%이었다. 특히, 실시예 1 내지 3 모두 뇌혈류 촉진 효과 및 신경안정에 관련이 있다고 알려진 GABA(γ-amino-n-butyric acid)를 함유하고 있었다. 또한, 실시예 1 내지 3 모두 성장호르몬의 분비를 촉진하여 근육 합성 증가 효과, 기초대사를 촉진 효과, 체지방 대사 효과, 항비만 효과, 면역증강 효과, 간보호 효과, 스트레스 완화 효과, 피부 재생 효과 등을 나타내는 것으로 알려진 오르니틴(ornithine)을 함유하고 있었다. 또한, 실시예 1 내지 3 모두 쌀에 부족한 아미노산인 라이신을 함유하고 있었다. Table 3 below shows the results of measuring the amino acid composition and content of each of the yogurts of Examples 1 to 3. In Example 1, 6 amino acids were detected, in Example 2, 7 amino acids, and in Example 3, 15 amino acids were detected. In particular, all of Examples 1 to 3 contained γ-amino-n-butyric acid (GABA) known to be related to cerebral blood flow promoting effect and nerve stability. In addition, all of Examples 1 to 3 promote the secretion of growth hormone, thereby increasing muscle synthesis, promoting basal metabolism, body fat metabolism, anti-obesity, immune enhancing, hepatoprotective, stress relieving, skin regeneration, etc. It contained ornithine known to exhibit. In addition, all of Examples 1 to 3 contained lysine, an amino acid lacking in rice.
(3) 요거트의 총 폴리페놀 및 플라보노이드 함량 분석(3) Analysis of total polyphenol and flavonoid content in yogurt
총 폴리페놀 함량은 Folin-Denis 법을 약간 변형하여 측정하였다. 구체적으로 시료 0.2 mL와 Folin reagent 0.2 mL를 혼합하여 실온에서 3분간 방치한 후, 10% sodium carbonate(Na2CO3) 용액 0.4 mL를 함께 섞어 40분 동안 암소에 방치한 후 마이크로플레이트 스펙트로포토미터(Epoch 2, Bio Tek Inc., Winooski, USA)를 사용하여 760 nm에서 흡광도를 측정하였다. Gallic acid를 표준물질로 사용하여 검량곡선을 작성한 후, 시료 중의 총 polyphenol 함량을 gallic acid equivalent(GAE)로 나타냈다. 실험은 3회 반복 측정하여 평균값(Mean)과 표준편차(S.D.)로 나타내었다. 총 플라보노이드 함량은 Davis 법을 변형하여 측정하였다. 구체적으로 시료 0.5 mL에 디에틸렌글라이콜 0.5 mL를 넣어 혼합한 후 1 N NaOH 10 μL를 가하여 37℃에서 1시간 동안 반응시킨 다음 마이크로플레이트 스펙트로포토미터(Epoch 2, Bio Tek Inc., Winooski, USA)를 사용하여 420 nm에서 흡광도를 측정하였다. Quercetin을 표준물질로 사용하여 검량곡선을 작성한 후, 시료 중의 총 플라보노이드 함량을 quercetin equivalent(QE)로 나타냈다. 실험은 3회 반복 측정하여 평균값 (Mean)과 표준편차(S.D.)로 나타내었다.Total polyphenol content was determined by a slight modification of the Folin-Denis method. Specifically, 0.2 mL of the sample and 0.2 mL of Folin reagent were mixed, left at room temperature for 3 minutes, mixed with 0.4 mL of 10% sodium carbonate (Na 2 CO 3 ) solution, left in the dark for 40 minutes, and microplate spectrophotometer (Epoch 2, Bio Tek Inc., Winooski, USA) was used to measure absorbance at 760 nm. After preparing a calibration curve using gallic acid as a standard material, the total polyphenol content in the sample was expressed as gallic acid equivalent (GAE). The experiment was repeated three times and expressed as the mean value (Mean) and standard deviation (SD). Total flavonoid content was determined by modifying the Davis method. Specifically, 0.5 mL of diethylene glycol was added to 0.5 mL of the sample, mixed, 10 μL of 1 N NaOH was added, reacted at 37 ° C. for 1 hour, and then absorbance was measured at 420 nm using a microplate spectrophotometer (Epoch 2, Bio Tek Inc., Winooski, USA). After drawing a calibration curve using quercetin as a standard material, the total flavonoid content in the sample was expressed as quercetin equivalent (QE). The experiment was repeated three times and expressed as the mean value (Mean) and standard deviation (SD).
식물체에 널리 함유되어 있는 페놀성 화합물들은 플라보노이드(flavonoid), 플라보놀(flavonols), 플라본(flavoones), 플라본(flavones), 이소플라본(isoflavones), 플라반-3-올(flavan-3-ols) 및 안토시아닌(anthocyanins)을 포함하고 항암, 항산화, 항바이러스, 항비만, 항알레르기성, 항궤양, 항균, 항염증 등 다양한 생리 활성 기능이 있는 것으로 보고되었다. 생체 내에서의 프리 라디칼 반응은 생체조직의 노화나 질병과 연관되어 있으며, 페놀성 물질 중 유지의 유리기 수용체인 히드록시 그룹은 유지 산패 초기 단계에 생성된 유리기들이 안정된 화합물들을 형성하도록 하여 산화를 억제한다. 아래 표 4에 실시예 1 내지 3의 총 폴리페놀 및 총 플라보노이드 함량을 나타내었다. 실시예 1 내지 3의 요거트는 모두 높은 총 폴리페놀 및 총 플라보노이드 함량을 나타내었다.Phenolic compounds widely contained in plants include flavonoids, flavonols, flavones, flavones, isoflavones, flavan-3-ols, and anthocyanins, and have various physiological activities such as anti-cancer, antioxidant, anti-viral, anti-obesity, anti-allergic, anti-ulcer, anti-bacterial, and anti-inflammatory. It has been reported that there is Free radical reactions in vivo are associated with aging or disease of biological tissues, and among phenolic substances, a hydroxyl group, which is a free radical acceptor of oil, inhibits oxidation by allowing free radicals generated in the early stage of oil rancidity to form stable compounds. Table 4 below shows the total polyphenol and total flavonoid contents of Examples 1 to 3. The yogurts of Examples 1 to 3 all showed high total polyphenol and total flavonoid contents.
(4) 요거트의 항산화 활성 측정(4) Measurement of antioxidant activity of yogurt
아래의 방법으로 실시예 1 내지 3 요거트의 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical 소거 활성을 측정하였다. 시료액 0.1 mL에 0.2 mM DPPH(in ethanol) 용액 0.9 mL를 가하여 37℃에서 30분 동안 방치하였다. 무첨가군은 시료 대신 에탄올 0.1mL를 넣어 반응시켰으며, 양성 대조군으로는 기존 항산화제인 BHA, BHT 및 아스코르브산을 사용하여 비교하였다. 그 후 마이크로플레이트 스펙트로포토미터(Epoch 2, Bio Tek Inc., Winooski, USA)로 517 nm에서 흡광도를 측정하였다. DPPH radical 소거 활성은 아래의 식에 의해 백분율로 계산하였다. 실험은 3회 반복하여 평균값(Mean)과 표준편차(S.D.)로 나타내었다.The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity of the yogurts of Examples 1 to 3 was measured by the following method. 0.9 mL of a 0.2 mM DPPH (in ethanol) solution was added to 0.1 mL of the sample solution and left at 37° C. for 30 minutes. The non-added group was reacted with 0.1 mL of ethanol instead of the sample, and as a positive control group, conventional antioxidants BHA, BHT, and ascorbic acid were used for comparison. Then, absorbance was measured at 517 nm with a microplate spectrophotometer (Epoch 2, Bio Tek Inc., Winooski, USA). DPPH radical scavenging activity was calculated as a percentage by the formula below. The experiment was repeated three times and expressed as the mean value (Mean) and standard deviation (S.D.).
또한, 아래의 방법으로 실시예 1 내지 3 요거트의 2.2-azino-bis-3-ehtylbenzthiazoline-6-sulphonic acid (ABTS) radical 소거 활성을 측정하였다. ABTS free radical의 생성을 위해 7.4 mM ABTS 용액과 2.6 mM 포타슘 퍼설페이트 용액을 제조하여 동량으로 혼합하여 암소에서 24시간 동안 반응시켰다. 그 후 ABTS 용액의 흡광도 값이 734 nm에서 0.7~1.0±0.02가 되도록 에탄올로 희석하였다. 일정 농도로 제조한 시료액 0.1 mL와 ABTS 용액 0.9 mL를 혼합한 후 37℃에서 30분 동안 반응시켰다. 무첨가군은 시료 대신 에탄올을 넣어 반응시켰다. 그 후 마이크로플레이트 스펙트로포토미터(Epoch 2, Bio Tek Inc., Winooski, USA)를 사용하여 734 nm에서 흡광도를 측정하였다. 실험은 3회 반복하여 평균값(Mean)과 표준편차(S.D.) 로 나타내었다.In addition, the 2.2-azino-bis-3-ehtylbenzthiazoline-6-sulphonic acid (ABTS) radical scavenging activity of the yogurts of Examples 1 to 3 was measured by the following method. To generate ABTS free radicals, a 7.4 mM ABTS solution and a 2.6 mM potassium persulfate solution were prepared, mixed in equal amounts, and reacted for 24 hours in the dark. After that, the ABTS solution was diluted with ethanol so that the absorbance value was 0.7~1.0±0.02 at 734 nm. After mixing 0.1 mL of the sample solution prepared at a certain concentration and 0.9 mL of the ABTS solution, it was reacted at 37 ° C. for 30 minutes. In the non-added group, ethanol was added instead of the sample to react. Then, absorbance was measured at 734 nm using a microplate spectrophotometer (Epoch 2, Bio Tek Inc., Winooski, USA). The experiment was repeated three times and expressed as the mean value (Mean) and standard deviation (S.D.).
DPPH radical 소거 활성은 페놀, 플라보노이드와 같은 페놀성 물질과도 상관관계가 있어 항산화 작용의 지표라고 알려져 있으며, 항산화 물질은 프리 라디칼에 전자를 공여하여 식품 중의 지방산화를 억제하고 인체 내 노화를 억제하는 작용을 하기 때문에 질병과 노화를 예방하는데 중요한 역할을 한다. ABTS는 항산화 존재 시 ABTS+의 흡광도가 억제되는 것에 기초하여 개발한 항산화 활성 측정 방법으로 ABTS가 포타슘퍼설페이트와 반응하여 청록색의 ABTS radical이 형성된 후 항산화제에 의해 라디칼이 제거되면서 청록색이 탈색되는 원리를 이용하여 소거 활성을 측정한다.DPPH radical scavenging activity is known to be an indicator of antioxidant activity because it is correlated with phenolic substances such as phenols and flavonoids. Antioxidants donate electrons to free radicals to suppress fatty acid oxidation in food and suppress aging in the human body. Therefore, it plays an important role in preventing disease and aging. ABTS is an antioxidant activity measurement method developed based on the suppression of absorbance of ABTS+ in the presence of antioxidants. After ABTS reacts with potassium persulfate to form blue-green ABTS radicals, the radicals are removed by antioxidants. The scavenging activity is measured using the principle of discoloration.
표 5에 실시예 1 내지 3의 DPPH radical 소거 활성능과 ABTS radical 소거 활성능을 나타내었다. 실시예 1 내지 3의 요거트는 모두 우수한 DPPH radical 소거 활성능과 ABTS radical 소거 활성능을 나타내었고, 이를 통해 본 발명의 제조방법으로 제조된 요거트는 우수한 항산화 효능을 나타내는 것을 확인하였다.Table 5 shows the DPPH radical scavenging activity and ABTS radical scavenging activity of Examples 1 to 3. All of the yogurts of Examples 1 to 3 exhibited excellent DPPH radical scavenging activity and ABTS radical scavenging activity, and through this, it was confirmed that the yogurt prepared by the manufacturing method of the present invention exhibited excellent antioxidant efficacy.
activity (%)ABTS radical scavenging
activity (%)
Claims (8)
상기 호화된 타락죽에 알파-아밀라아제를 첨가하여 당화된 타락죽을 수득하는 단계;
상기 당화된 타락죽에 스트렙토코코스속(Streptococcus), 락토바실러스속(Lactobacillus) 및 비피도박테리움속(Bifidobacterium) 으로 이루어진 군에서 선택된 적어도 하나의 유산균을 첨가하여 20 내지 60℃에서 발효시키는 단계;를 포함하는 타락죽을 포함하는 요거트의 제조방법.
Applying heat to a mixture of rice flour and milk to obtain luxurious tarak porridge;
Obtaining saccharified tarak porridge by adding alpha-amylase to the gelatinized tarak porridge;
Adding at least one lactic acid bacterium selected from the group consisting of Streptococcus , Lactobacillus and Bifidobacterium to the saccharified tark porridge and fermenting at 20 to 60 ° C. Method for producing yogurt containing tark porridge.
The method of claim 1, wherein the rice flour is at least one selected from the group consisting of black rice flour and white rice flour.
The method according to claim 1, wherein the rice flour is obtained by immersing 100 parts by weight of rice in 300 to 500 parts by weight of purified water at 15 to 30 ° C, removing the purified water after 5 to 20 hours, and then pulverizing.
The method of claim 1, wherein sweet pumpkin is further added to the mixture before applying the heat.
The method of claim 1, wherein the milk contains omega-3 and omega-6 in a weight ratio of 1:3 to 1:5.
The method according to claim 1, wherein the lactic acid bacteria are Streptococcus thermophiles, Lactobacillus acidophilus , Lactobacillus delbrueckii ssp. bulgaricus and Bifidobacterium animalis ssp. lactis . A method for producing yogurt containing porridge.
The method of claim 1, wherein the yogurt contains omega-3 and omega-6 in a weight ratio of 1:3 to 1:5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220007730A KR20230111814A (en) | 2022-01-19 | 2022-01-19 | Method for manufacturing yogurt containing rice milk |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220007730A KR20230111814A (en) | 2022-01-19 | 2022-01-19 | Method for manufacturing yogurt containing rice milk |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230111814A true KR20230111814A (en) | 2023-07-26 |
Family
ID=87427758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220007730A KR20230111814A (en) | 2022-01-19 | 2022-01-19 | Method for manufacturing yogurt containing rice milk |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20230111814A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102259148B1 (en) | 2021-01-04 | 2021-06-01 | 이승종 | Manufacturing method of greek yogurt |
-
2022
- 2022-01-19 KR KR1020220007730A patent/KR20230111814A/en unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102259148B1 (en) | 2021-01-04 | 2021-06-01 | 이승종 | Manufacturing method of greek yogurt |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101814420B1 (en) | Method for producing mixed Chunggukjang and Doenjang using Bacillus subtilis SY07 strain and mixed Chunggukjang and Doenjang produced by the same method | |
Herken et al. | Use of carob flour in the production of tarhana | |
Maleki et al. | Antioxidant activity of fermented Hazelnut milk | |
Bae et al. | Production of sesaminol and antioxidative activity of fermented sesame with Lactobacillus plantarum P8, Lactobacillus acidophilus ATCC 4356, Streptococcus thermophilus S10 | |
KR20080111270A (en) | Phellinus linteus extraxt, grain syrup and pepper paste comprising thereof | |
Abdullah et al. | Assessment of angiotensin converting enzyme inhibitory activity and quality attributes of yoghurt enriched with Cinnamomum verum, Elettaria cardamomum, Beta vulgaris and Brassica oleracea | |
KR102387269B1 (en) | Composition and method for yogurt with enhanced GABA using barley and yogurt produced by the same | |
KR20230111814A (en) | Method for manufacturing yogurt containing rice milk | |
KR20150014014A (en) | Fermented mulberry composition with antioxidant activity and method of preparing the same | |
KR101042276B1 (en) | Method for manufacturing black garlic makgeoli | |
KR101558134B1 (en) | Soybean paste and method for preparing the same | |
KR102249821B1 (en) | Method for manufacturing perilla oil improved expiration date and increased omega-3 | |
KR20140147934A (en) | Funtional drink by mixed fermentation of oak mushrooms extract and whey and manufacturing metond thereof | |
KR20210115216A (en) | Manufacturing method of rice punch powder to improve growth and development for kids and youths | |
KR20170127831A (en) | Method for preparing γ-aminobutyricacid concentrate using by-product of rice | |
KR20110029611A (en) | Chocolate containing soybean paste and method for preparing the same | |
KR101714964B1 (en) | Method for producing malt powder containing black barley | |
KR20170053536A (en) | Beverages for preventing respiratory disease and hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
KR101714963B1 (en) | Method for producing three color germinated brown rice powder using three color brown rice | |
KR101660382B1 (en) | The manufacturing method of safflower drinking using powder fermentation for safflower seeds | |
JP2010022279A (en) | Sphingolipid-enriched malt and method for producing the same | |
KR20190079899A (en) | Jellied food with Immune Enhancing Effect Containing Soy Milk and Lactic Acid Bacteria and Its Preparation Method | |
Son et al. | Changes in physicochemical characteristics and nutritional values of soybean, meju, and doenjang by varying sowing periods | |
KR101852032B1 (en) | Beverages for preventing hyperlipidemia containing Platycodon grandiflorum and its preparing method | |
KR102129756B1 (en) | Composition for Law-salted Soybean Paste Using Rice and Manufacturing Method the Same |